Chile vs Türkiye: Life science patents granted, by filing office
Chile
0 patents
in 2023
Türkiye
0 patents
in 2023
Chile rank
48th
Türkiye rank
48th
Life science patents granted, by filing office over time
- Chile
- Türkiye
How they compare
Chile currently reports 0 patents against 0 patents in Türkiye, a difference of 0 patents.
The two have swapped places 2 times across 44 shared years of data; in 1980 it was Türkiye ahead.
Chile ranks 48th and Türkiye ranks 48th of 70 countries.
Across the 5 decades both report, Chile averaged higher in 1 and Türkiye in 2.
Head to head by decade
| Decade | Chile | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0 patents | 7.2 patents | 7.2 patents | Türkiye |
| 1990s | 0 patents | 26.3 patents | 26.3 patents | Türkiye |
| 2000s | 0.4 patents | 0 patents | 0.4 patents | Chile |
| 2010s | 0 patents | 0 patents | 0 patents | — |
| 2020s | 0 patents | 0 patents | 0 patents | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by filing office, Chile or Türkiye?
- Chile, at 0 patents against 0 patents in Türkiye as of 2023.
- What is the difference in life science patents granted, by filing office between Chile and Türkiye?
- 0 patents, with Chile ahead.
- How many years of comparable data are there for Chile and Türkiye?
- 44 years are reported by both, from 1980 to 2023.
- How do Chile and Türkiye rank globally for life science patents granted, by filing office?
- Chile ranks 48th and Türkiye ranks 48th of 70 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by filing office. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.